7 pending office actions • 4 art units • 5 examiners • 0 of 7 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (43%) |
| §112 only | 1 (14%) |
| No statute on record | 3 (43%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MORNHINWEG, JEFFREY P | 2 | 36.3% | +33.3% |
| CONSTANTINE, CHARLES Z | 2 | 58.4% | +49.3% |
| LEESER, ERICH A | 1 | 81.6% | +13.5% |
| MCCLAIN, TYNESHA L. | 1 | 15.6% | +24.8% |
| MARTIN, PAUL C | 1 | 42.0% | +21.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17234472 | High-Purity Rubusoside And Process For Producing Of The Same | MCCLAIN, TYNESHA L. | 79d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 15779766 | PROCESS FOR PRODUCING HIGH PURITY STEVIOL GLYCOSIDES | MARTIN, PAUL C | 120d overdue |
| 18142850 | GLUCOSYL STEVIA COMPOSITION | CONSTANTINE, CHARLES Z | 25d overdue |
| 18544879 | GLUCOSYL STEVIA COMPOSITION | CONSTANTINE, CHARLES Z | 17d overdue |
| 18488248 | STEVIA COMPOSITION | LEESER, ERICH A | 15d overdue |
| 16697047 | PROCESS FOR MANUFACTURING A SWEETENER AND USE THEREOF | MORNHINWEG, JEFFREY P | 11d overdue |
| 18413708 | STEVIA EXTRACTS | MORNHINWEG, JEFFREY P | 71d |
| 17234472 | High-Purity Rubusoside And Process For Producing Of The Same | MCCLAIN, TYNESHA L. | 79d |
| Art Unit | Apps |
|---|---|
| 1793 | 3 |
| 1657 | 2 |
| 1622 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18413708 | STEVIA EXTRACTS | MORNHINWEG, JEFFREY P | 1793 | §103 | Non-Final OA | 71d | Pending | Jan 16, 2024 |
| 18544879 | GLUCOSYL STEVIA COMPOSITION | CONSTANTINE, CHARLES Z | 1657 | Other | Non-Final OA | 17d overdue | Pending | Dec 19, 2023 |
| 18488248 | STEVIA COMPOSITION | LEESER, ERICH A | 1622 | Other | Non-Final OA | 15d overdue | Pending | Oct 17, 2023 |
| 18142850 | GLUCOSYL STEVIA COMPOSITION | CONSTANTINE, CHARLES Z | 1657 | Other | Final Rejection | 25d overdue | Pending | May 03, 2023 |
| 17234472 | High-Purity Rubusoside And Process For Producing Of The Same | MCCLAIN, TYNESHA L. | 1793 | §103 | Non-Final OA | 79d | Pending | Apr 19, 2021 |
| 16697047 | PROCESS FOR MANUFACTURING A SWEETENER AND USE THEREOF | MORNHINWEG, JEFFREY P | 1793 | §103 | Final Rejection | 11d overdue | Pending | Nov 26, 2019 |
| 15779766 | PROCESS FOR PRODUCING HIGH PURITY STEVIOL GLYCOSIDES | MARTIN, PAUL C | 1653 | §112 | Final Rejection | 120d overdue | Pending | May 29, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial